nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—adrenal gland cancer	0.861	1	CbGaD
Tolvaptan—AVPR2—urine—adrenal gland cancer	0.0259	0.676	CbGeAlD
Tolvaptan—AVPR1A—Peptide GPCRs—GNRHR—adrenal gland cancer	0.00657	0.0658	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—GNRHR—adrenal gland cancer	0.00652	0.0654	CbGpPWpGaD
Tolvaptan—AVPR1A—adrenal gland—adrenal gland cancer	0.00599	0.156	CbGeAlD
Tolvaptan—AVPR2—Arf6 trafficking events—TSHR—adrenal gland cancer	0.00501	0.0502	CbGpPWpGaD
Tolvaptan—CYP3A4—urine—adrenal gland cancer	0.00395	0.103	CbGeAlD
Tolvaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—PRKACA—adrenal gland cancer	0.00386	0.0387	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—TSHR—adrenal gland cancer	0.00351	0.0352	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—TSHR—adrenal gland cancer	0.00348	0.0349	CbGpPWpGaD
Tolvaptan—AVPR2—Aquaporin-mediated transport—PRKACA—adrenal gland cancer	0.00337	0.0337	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00313	0.0314	CbGpPWpGaD
Tolvaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—GNAS—adrenal gland cancer	0.00313	0.0313	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0028	0.028	CbGpPWpGaD
Tolvaptan—AVPR2—Aquaporin-mediated transport—GNAS—adrenal gland cancer	0.00273	0.0273	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0023	0.0231	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00207	0.0208	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00206	0.0206	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00187	0.0188	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00168	0.0168	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00158	0.0158	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00157	0.0157	CbGpPWpGaD
Tolvaptan—AVPR2—Arf6 trafficking events—CTNNB1—adrenal gland cancer	0.0014	0.014	CbGpPWpGaD
Tolvaptan—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00138	0.0139	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00134	0.0134	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00124	0.0124	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00123	0.0124	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00111	0.0111	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0011	0.011	CbGpPWpGaD
Tolvaptan—Vismodegib—ABCB1—adrenal gland cancer	0.000963	1	CrCbGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000946	0.00948	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000939	0.00941	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—POMC—adrenal gland cancer	0.000903	0.00904	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000892	0.00894	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000886	0.00887	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.000843	0.00845	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000837	0.00838	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00081	0.00812	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000804	0.00806	CbGpPWpGaD
Tolvaptan—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000757	0.00758	CbGpPWpGaD
Tolvaptan—ABCB1—adrenal cortex—adrenal gland cancer	0.000741	0.0193	CbGeAlD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000662	0.00664	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.000646	0.00648	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.000642	0.00643	CbGpPWpGaD
Tolvaptan—ABCB1—gonad—adrenal gland cancer	0.000614	0.016	CbGeAlD
Tolvaptan—ABCB1—pituitary gland—adrenal gland cancer	0.000599	0.0156	CbGeAlD
Tolvaptan—ABCB1—adrenal gland—adrenal gland cancer	0.000535	0.0139	CbGeAlD
Tolvaptan—AVPR1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000534	0.00535	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000531	0.00532	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00049	0.00491	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000487	0.00488	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000485	0.00486	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000482	0.00483	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000479	0.00479	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000476	0.00477	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000475	0.00476	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000473	0.00474	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000465	0.00466	CbGpPWpGaD
Tolvaptan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000456	0.00457	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000445	0.00446	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000442	0.00443	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000441	0.00442	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000435	0.00436	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000433	0.00434	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000433	0.00433	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00043	0.00431	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000429	0.0043	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000418	0.00419	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000415	0.00416	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00041	0.00411	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000377	0.00378	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00037	0.0037	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000355	0.00356	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000331	0.00332	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—POMC—adrenal gland cancer	0.00033	0.00331	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—POMC—adrenal gland cancer	0.000328	0.00328	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00031	0.00311	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000308	0.00309	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00029	0.00291	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000288	0.00288	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000287	0.00287	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000285	0.00285	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000277	0.00278	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000275	0.00276	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000263	0.00264	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000262	0.00263	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000261	0.00262	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00026	0.00261	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000256	0.00256	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TSHR—adrenal gland cancer	0.000254	0.00254	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000253	0.00254	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000252	0.00252	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00025	0.0025	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MEN1—adrenal gland cancer	0.00024	0.00241	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MEN1—adrenal gland cancer	0.000239	0.00239	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000189	0.0019	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000187	0.00187	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000185	0.00186	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000183	0.00184	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000182	0.00182	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000169	0.0017	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—POMC—adrenal gland cancer	0.000168	0.00169	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000156	0.00156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDC42—adrenal gland cancer	0.000154	0.00155	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000154	0.00154	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.00015	0.0015	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF2—adrenal gland cancer	0.000149	0.00149	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000149	0.00149	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GNAS—adrenal gland cancer	0.000148	0.00148	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000145	0.00145	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000144	0.00144	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000132	0.00132	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000125	0.00125	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TERT—adrenal gland cancer	0.000124	0.00124	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SDHB—adrenal gland cancer	0.000118	0.00119	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000109	0.00109	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BAD—adrenal gland cancer	0.000108	0.00108	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—adrenal gland cancer	0.0001	0.001	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—adrenal gland cancer	9.94e-05	0.000996	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BRAF—adrenal gland cancer	9.88e-05	0.00099	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BRAF—adrenal gland cancer	9.81e-05	0.000983	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	9.71e-05	0.000973	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—adrenal gland cancer	9.58e-05	0.00096	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—adrenal gland cancer	9.51e-05	0.000953	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	8.86e-05	0.000887	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	8.69e-05	0.00087	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	8.15e-05	0.000817	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—RRM1—adrenal gland cancer	7.63e-05	0.000764	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SDHD—adrenal gland cancer	7.63e-05	0.000764	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SDHB—adrenal gland cancer	7.29e-05	0.000731	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	7.18e-05	0.000719	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.14e-05	0.000716	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CTNNB1—adrenal gland cancer	7.09e-05	0.00071	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	6.88e-05	0.00069	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	5.78e-05	0.000579	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MED12—adrenal gland cancer	5.69e-05	0.00057	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—adrenal gland cancer	5.66e-05	0.000567	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—adrenal gland cancer	5.62e-05	0.000563	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—adrenal gland cancer	4.75e-05	0.000476	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—adrenal gland cancer	4.72e-05	0.000473	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SDHD—adrenal gland cancer	4.7e-05	0.000471	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—RRM1—adrenal gland cancer	4.7e-05	0.000471	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PRKACA—adrenal gland cancer	4.15e-05	0.000416	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MED12—adrenal gland cancer	3.5e-05	0.000351	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GNAS—adrenal gland cancer	3.36e-05	0.000337	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	2.56e-05	0.000256	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—adrenal gland cancer	2.26e-05	0.000227	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GNAS—adrenal gland cancer	2.07e-05	0.000208	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	2.03e-05	0.000204	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.81e-05	0.000181	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.39e-05	0.00014	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	1.11e-05	0.000111	CbGpPWpGaD
